RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

The number of Australians vaccinated against influenza is "worryingly low", health experts say, as new data reveal the winter flu season has begun.

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

Kennedy’s decision to “retire” the previous 17-member Advisory Committee on Immunization Practices was widely decried by ...

After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...

Here’s what causes colds to spread so easily, how long they are usually contagious and how they’re most commonly treated.